Summary

U.S. Microcarrier Beads Market Summary

The U.S. microcarrier beads market size was estimated at USD 442.8 million in 2024 and is projected to reach USD 821.5 million by 2030, growing at a CAGR of 11.04% from 2025 to 2030. The market growth is driven by increasing demand for cell-based therapies, advancements in biopharmaceutical manufacturing, and the rising adoption of microcarrier-based culture systems for large-scale cell production.

Moreover, growing investments in regenerative medicine and tissue engineering, along with technological innovations in microcarrier design and materials, are expected to drive market growth throughout the forecast period. The U.S. has seen a sharp increase in demand for microcarriers, largely driven by the expanding production of biologics and cell-based vaccines. Microcarrier beads allow for the efficient expansion of adherent cells, which are crucial in producing monoclonal antibodies, viral vectors, and vaccines. As the biologics segment continues to outpace traditional pharmaceuticals, microcarrier-based cell culture systems are increasingly being adopted to meet scalability requirements. Companies like Thermo Fisher Scientific and Corning Incorporated are investing in product enhancements to support high-throughput, scalable manufacturing processes. For instance, Thermo Fisher continues to expand its Gibco microcarrier product line to cater to high-density cell culture applications, particularly in vaccine production and viral vector manufacturing.

Microcarrier beads offer notable cost advantages over traditional planar culture methods, such as reduced labor, lower media usage, and smaller facility footprints. These economic benefits, combined with improved consistency and scalability, make microcarriers highly attractive for biomanufacturers. Moreover, microcarrier-based systems align well with the FDA’s cGMP standards, aiding in regulatory approval processes. Companies like Sartorius and Eppendorf are promoting closed-system bioreactor setups with pre-sterilized, ready-to-use microcarriers to facilitate cGMP-compliant cell culture. In May 2024, Eppendorf launched the BioBLU 5p High-Density Vessel designed for microcarrier applications in regulated production environments.

The U.S. microcarrier beads industry is also being propelled by innovation in microcarrier materials (e.g., biodegradable, macroporous, and serum-free options) and strategic collaborations. For example, in April 2024, Corning announced a partnership with a U.S.-based gene therapy firm to co-develop optimized microcarrier surfaces tailored for stem cell expansion. Additionally, Thermo Fisher and Lonza have both announced increased investments in microcarrier-compatible bioproduction facilities. These partnerships and technological advancements are improving cell yields, facilitating easier harvesting, and enhancing compatibility with automation and single-use systems. The growing ecosystem of support products and services around microcarriers-such as automated cell counters, perfusion systems, and real-time monitoring tools-is further reinforcing U.S. microcarrier beads industry growth.

U.S. Microcarrier Beads Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the U.S. microcarrier beads market report based on type, material, target cell type, application, and end use:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Collagen Coated Beads
o Cationic Beads
o Polystyrene
o PVOH
o Others
• Protein Coated Beads
o Collagen
o Cellulose
o Polystyrene
o Others
• Untreated Beads
o Cellulose
o Polystyrene
o Dextran
o Others
• Others
o Alginate
o PVOH
o Others
• Material Outlook (Revenue, USD Million, 2018 - 2030)
• Natural Materials
o Cellulose
o Collagen
o Alginate
o Other Natural Materials
• Synthetic Materials
o Polystyrene
o Dextran
o PVOH
o Other Synthetic Materials
• Target Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
• CHO
• HEK
• Vero
• MSCs
• iPSCs
• Others
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Biopharmaceutical Production
o Vaccine Production
o Therapeutic Production
• Regenerative Medicine
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations & Contract Manufacturing Organizations
• Academic & Research Institutes

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Material Segment
1.2.3. Target Cell Type Segment
1.2.4. Application Segment
1.2.5. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. U.S. Microcarrier Beads Market Variables & Trends
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growth of the biopharmaceutical industry
3.2.1.2. Rising demand for cell-based therapies
3.2.2. Market restraint analysis
3.2.2.1. Raw material price fluctuations
3.2.2.2. Competition from alternatives
3.3. U.S. Microcarrier Beads Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Microcarrier Beads Market: Type Estimates & Trend Analysis
4.1. Type Segment Dashboard
4.2. U.S. Microcarrier Beads Market Type Movement Analysis
4.3. U.S. Microcarrier Beads Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Collagen Coated Beads
4.4.1. Collagen Coated Beads Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5. Cationic Beads
4.5.1. Cationic Beads Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5.2. Polystyrene
4.5.2.1. Polystyrene Beads Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5.3. PVOH
4.5.3.1. PVOH Beads Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others Beads Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.6. Protein Coated Beads
4.6.1. Protein Coated Beads Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.6.2. Collagen
4.6.2.1. Collagen Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.6.3. Cellulose
4.6.3.1. Cellulose Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.6.4. Polystyrene
4.6.4.1. Polystyrene Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.6.5. Others
4.6.5.1. Others Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.7. Untreated Beads
4.7.1. Untreated Beads Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.7.2. Cellulose
4.7.2.1. Cellulose Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.7.3. Polystyrene
4.7.3.1. Polystyrene Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.7.4. Dextran
4.7.4.1. Dextran Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.7.5. Others
4.7.5.1. Others Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Others Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.8.2. Alginate
4.8.2.1. Alginate Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.8.3. PVOH
4.8.3.1. PVOH Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.8.4. Other
4.8.4.1. Others Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Microcarrier Beads Market: Material Estimates & Trend Analysis
5.1. Material Segment Dashboard
5.2. U.S. Microcarrier Beads Market Material Movement Analysis
5.3. U.S. Microcarrier Beads Market Size & Trend Analysis, by Material, 2018 to 2030 (USD Million)
5.4. Natural Materials
5.4.1. Natural Materials Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.1.1. Cellulose
5.4.1.1.1. Cellulose Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.1.2. Collagen
5.4.1.2.1. Collagen Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.1.3. Alginate
5.4.1.3.1. Alginate Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.1.4. Other Natural Materials
5.4.1.4.1. Other Natural Materials Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5. Synthetic Materials
5.5.1. Synthetic Materials Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.1.1. Polystyrene
5.5.1.1.1. Polystyrene Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.1.2. Dextran
5.5.1.2.1. Dextran Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.1.3. PVOH
5.5.1.3.1. PVOH Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.1.4. Other Synthetic Materials
5.5.1.4.1. Other Synthetic Materials Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Microcarrier Beads Market: Target Cell Estimates & Trend Analysis
6.1. Target Cell Type Segment Dashboard
6.2. U.S. Microcarrier Beads Market Target Cell Type Movement Analysis
6.3. U.S. Microcarrier Beads Market Size & Trend Analysis, by Target Cell Type, 2018 to 2030 (USD Million)
6.4. CHO
6.4.1. CHO Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5. HEK
6.5.1. HEK Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6. Vero
6.6.1. Vero Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7. MSCs
6.7.1. MSCs Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8. iPSCs
6.8.1. iPSCs Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.9. Others
6.9.1. Others Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Microcarrier Beads Market: Application Estimates & Trend Analysis
7.1. Application Segment Dashboard
7.2. U.S. Microcarrier Beads Market Application Movement Analysis
7.3. U.S. Microcarrier Beads Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.3.1. Biopharmaceutical Production
7.3.1.1. Biopharmaceutical Production Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.1.1.1. Vaccine Production
7.3.1.1.1.1. Vaccine Production Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.1.1.2. Therapeutic Production
7.3.1.1.2.1. Therapeutic Production Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.1.2. Regenerative Medicine
7.3.1.2.1. Regenerative Medicine Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. U.S. Microcarrier Beads Market: End Use Estimates & Trend Analysis
8.1. End Use Segment Dashboard
8.2. U.S. Microcarrier Beads Market End Use Movement Analysis
8.3. U.S. Microcarrier Beads Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Pharmaceutical & Biotechnology Companies
8.4.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.5. Contract Research Organizations & Contract Manufacturing Organizations
8.5.1. Contract Research Organizations & Contract Manufacturing Organizations Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6. Academic & Research Institutes
8.6.1. Academic & research institutes Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Danaher Corporation
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Sartorius AG
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Corning Incorporated
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Merck KGaA
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Bio-Rad Laboratories, Inc.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Creative BioMart
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Repligen (Tantti)
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Darling Ingredients
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. KURARAY CO., LTD.
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives